KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Return on Assets (2016 - 2025)

Historic Return on Assets for Arbutus Biopharma (ABUS) over the last 16 years, with Q3 2025 value amounting to 0.42%.

  • Arbutus Biopharma's Return on Assets rose 900.0% to 0.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42%, marking a year-over-year increase of 900.0%. This contributed to the annual value of 0.51% for FY2024, which is 800.0% down from last year.
  • Latest data reveals that Arbutus Biopharma reported Return on Assets of 0.42% as of Q3 2025, which was up 900.0% from 0.49% recorded in Q2 2025.
  • Arbutus Biopharma's 5-year Return on Assets high stood at 0.31% for Q2 2022, and its period low was 0.62% during Q1 2025.
  • Moreover, its 5-year median value for Return on Assets was 0.47% (2021), whereas its average is 0.44%.
  • As far as peak fluctuations go, Arbutus Biopharma's Return on Assets skyrocketed by 9200bps in 2021, and later tumbled by -1400bps in 2024.
  • Arbutus Biopharma's Return on Assets (Quarter) stood at 0.41% in 2021, then increased by 16bps to 0.35% in 2022, then crashed by -38bps to 0.48% in 2023, then fell by -7bps to 0.51% in 2024, then grew by 18bps to 0.42% in 2025.
  • Its Return on Assets was 0.42% in Q3 2025, compared to 0.49% in Q2 2025 and 0.62% in Q1 2025.